BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
VEGFA
,
Coagulation
,
Ischemia
,
Hippocampus
,
Avian flu virus
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PU.1
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Whole blood
Neutrophil of bone marrow
Leukocyte (polymorphonuclear) of peripheral blood
Microglial cell
Mononuclear cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Fungal keratitis
Fusarium infection
Protozoan infection
Salmonella infection
Infection due to Enterobacteriaceae
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
poly ICLC
Immunoglobulin M
ipilimumab
Ions
dihydroquinghaosu
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
BACH2
EN1
CASP1
SPI1
EHF
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Adipocyte PU.1 knockout promotes insulin sensitivity in HFD-fed obese mice.
Inflammatory signals directly instruct PU.1 in HSCs via TNF.
The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1β eRNA and…
Temporal autoregulation during human PU.1 locus SubTAD formation.
Calcitriol Regulates the Differentiation of IL-9-Secreting Th9 Cells by Modulating the Transcription…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
PET Imaging of Subjects Using 124I-PU-AD
A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in H…
Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Demen…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ